Follow along with the video below to see how to install our site as a web app on your home screen.
Note: This feature currently requires accessing the site using the built-in Safari browser.
You are using an out of date browser. It may not display this or other websites correctly. You should upgrade or use an alternative browser.
Wed news: BioNTech buying Biotheus. FDA’s Califf lists hopes for his successor. Amgen loses $12B market cap from hidden spreadsheet tab. TRex Bio raises $84M. London is Europe’s life science capitol. See more on our front page
I'm on the oncology side of Eisai. This business is going away fast. New products in2 of the top indications, breast and HCC. Also, Merck owns 51% of Lenvima. Shari either left because she knows something is coming and its a good time to get out, she was forced out or, she has another job. Look at the turn over on this side, it's crazy and, most people will not come over here to work. Nice people but, it's not a career.
She was an incompetent, politically savage, fraud from the time she was corporate controller. Long hours, ineffective and intellectually deficient. A complete charade.
Lots of sexist comments.... she outworked everyone in front of her, and made her way up the ladder... good leader ... lots of jealous men out there looking to trash a woman who outworked them